@cytocom.com
Cytocom is a specialty biotech company, founded by patients, specializing in repurposing of drugs
π’
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
About
Description
Cytocom, Inc. With a primary focus on autoimmune diseases, infectious diseases, inflammatory diseases, and cancers, Cytocom is dedicated to providing effective solutions for patients. Their innovative approach utilizes the Advanced Immunomodulating Multi-receptor System (AIMSβ’), a proprietary drug discovery and development platform.
Through AIMSβ’, Cytocom explores the relationship between noroxymorphone and proenkephalin analogs, analyzing how multiple factors impact pharmacokinetic-pharmacodynamic relationships, potency, and selectivity. The result is the creation of powerful immune therapies that offer improved properties to address specific patient needs, surpassing the results achieved by other published immunotherapy approaches. Cytocom offers a diverse range of program therapies under various platforms, including the CYTO-200 Noroxymorphone Platform, CYTO-400 Proenkephalin Platform, and CYTO-600 TLR5 Platform.
These programs target multiple indications such as cancer, inflammatory diseases, autoimmune disorders, and infectious diseases. With a commitment to scientific excellence and patient well-being, Cytocom is revolutionizing the field of immunotherapy and striving to provide effective treatment options for those in need. For more information or general inquiries, visit their website or contact them directly
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere π
All services online
Top brand categories